Effects of Lobeglitazone, a Novel Thiazolidinedione, on Bone Mineral Density in Patients with Type 2 Diabetes Mellitus over 52 Weeks

BACKGROUND: The aim of this multicenter, randomized, double-blind study was to examine the effect of lobeglitazone, a novel thiazolidinedione, on the changes in bone mineral density (BMD) in patients with type 2 diabetes mellitus. METHODS: A 24-week, double-blinded phase was followed by a 28-week, o...

Descripción completa

Detalles Bibliográficos
Autores principales: Lim, Soo, Kim, Kyoung Min, Kim, Sin Gon, Kim, Doo Man, Woo, Jeong-Taek, Chung, Choon Hee, Ko, Kyung Soo, Park, Jeong Hyun, Park, Yongsoo, Kim, Sang Jin, Jang, Hak Chul, Choi, Dong Seop
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Diabetes Association 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5663677/
https://www.ncbi.nlm.nih.gov/pubmed/29086536
http://dx.doi.org/10.4093/dmj.2017.41.5.377

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5663677/
https://www.ncbi.nlm.nih.gov/pubmed/29086536
http://dx.doi.org/10.4093/dmj.2017.41.5.377

Ejemplares similares